Zaker I. Schwabkey
No Rating Available
(Learn About Our Rating System)

Zaker I. Schwabkey, MD

Languages spoken: Arabic, English

Clinical Locations

Huntsman Cancer Institute - Cancer Hospital North

4K, Hematology Inpatient
Salt Lake City
801-646-9500

Huntsman Cancer Institute - Cancer Research North

Clinic 2D/E, BMT/Hematology
Salt Lake City
801-585-2626

University of Utah Hospital

Hematology Clinic
Salt Lake City
801-585-3229

  • Dr. Zaker Schwabkey is an Assistant Professor of Medicine and a Clinical Investigator in the Division of Hematology & Hematologic Malignancies at the University of Utah, Huntsman Cancer Institute. Dr. Schwabkey is an expert in treating myeloid neoplasms specifically acute myeloid leukemia, myelodysplastic syndromes, chronic myeloid leukemia, and myeloproliferative neoplasms. Dr. Schwabkey is committed to teaching the next generation of doctors and conducts clinical and translational research in his areas of expertise. His work has been published in esteemed journals such as Science Translational Medicine and Lancet Haematology and presented at national and international scientific meetings.

    Dr. Schwabkey completed his postdoctoral research fellowship in genomic and cancer medicine at the University of Texas MD Anderson Cancer Center in Houston, TX. He completed his internal medicine residency at the Albany Medical College in Albany, NY followed by a fellowship in hematology and medical oncology at the Moffitt Cancer Center & Research Institute in Tampa, FL where he also served as a chief fellow.

    Specialties

    Board Certification

    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Hematology)
    American Board of Internal Medicine (Sub: Medical Oncology)
    Educational Commission for Foreign Medical Graduates

  • Dr. Zaker Schwabkey is an Assistant Professor of Medicine and a Clinical Investigator in the Division of Hematology & Hematologic Malignancies at the University of Utah, Huntsman Cancer Institute. Dr. Schwabkey is an expert in treating myeloid neoplasms specifically acute myeloid leukemia, myelodysplastic syndromes, chronic myeloid leukemia, and myeloproliferative neoplasms. Dr. Schwabkey is committed to teaching the next generation of doctors and conducts clinical and translational research in his areas of expertise. His work has been published in esteemed journals such as Science Translational Medicine and Lancet Haematology and presented at national and international scientific meetings.

    Dr. Schwabkey completed his postdoctoral research fellowship in genomic and cancer medicine at the University of Texas MD Anderson Cancer Center in Houston, TX. He completed his internal medicine residency at the Albany Medical College in Albany, NY followed by a fellowship in hematology and medical oncology at the Moffitt Cancer Center & Research Institute in Tampa, FL where he also served as a chief fellow.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Academic Divisions Hematology & Hematologic Malignancies
    Board Certification
    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Hematology)
    American Board of Internal Medicine (Sub: Medical Oncology)
    Educational Commission for Foreign Medical Graduates

    Education history

    Fellowship Hematology/Oncology - Moffitt Cancer Center Chief Fellow
    Fellowship Hematology/Oncology - Moffitt Cancer Center Fellow
    Residency Internal Medicine - Albany Medical College Resident
    Postdoctoral Fellowship Cancer Medicine - University of Texas MD Anderson Cancer Center Postdoctoral Research Fellow
    Internship Jordan Hospital Transitional Internship
    Professional Medical Medicine - Jordan University of Science & Technology School of Medicine M.D.

    Selected Publications

    Journal Article

    1. Rami S Komrokji, MBBS, Luca Lanino, MD, Somedeb Ball, MD, Jan P Bewersdorf, MD, Monia Marchetti, MD, Giulia Maggioni, MD, Erica Travaglino, BSc, Najla H Al Ali, MSc, Pierre Fenaux, MD, Uwe Platzbecker, MD, Valeria Santini, MD, Maria Diez-Campelo, MD, Avani Singh, MD, Akriti Gupta Jain, MD, Luis E Aguirre, MD, Sarah M Tinsley-Vance, PhD, Zaker I Schwabkey, MD, Onyee Chan, MD, Zhouer Xie, MD, Andrew M Brunner, MD, Andrew T Kuykendall, MD, Prof John M Bennett, MD, Rena Buckstein, MD, Rafael Bejar, MD, Hetty E Carraway, MD, Amy E DeZern, MD, Elizabeth A Griffiths, MD, Stephanie Halene, MD, Robert P Hasserjian, MD, Jeffrey Lancet, MD, Alan F List, MD, Sanam Loghavi, MD, Olatoyosi Odenike, MD, Eric Padron, MD, Mrinal M Patnaik, MBBS, Gail J Roboz, MD, Maximilian Stahl, MD, Prof Mikkael A Sekeres, MD, David P Steensma, MD, Michael R Savona, MD, Justin Taylor, MD, Mina L Xu, MD, Kendra Sweet, MD, David A Sallman, MD, Stephen D Nimer, MD, Christopher S Hourigan, DM, Andrew H Wei, MBBS, Elisabetta Sauta, PhD, Saverio DAmico, MSc, Gianluca Curriculum Vitae Zaker I Schwabkey, MD 3 Asti, MSc, Gastone Castellani, PhD, Mattia Delleani, MSc, Alessia Campagna, MD, Uma M Borate, MD, Guillermo Sanz, MD, Fabio Efficace, PhD, Steven D Gore, MD, Tae Kon Kim, MD, Navel Daver, MD, Guillermo Garcia-Manero, MD, Maria Rozman, MD, Alberto Orfao, MD, Sa A Wang, MD, M Kathryn Foucar, MD, Ulrich Germing, MD, Torsten Haferlach, MD, Phillip Scheinberg, MD, Yasushi Miyazaki, MD, Marcelo Iastrebner, MD, Austin Kulasekararaj, MD, Thomas Cluzeau, MD, Shahram Kordasti, MD, Arjan A van de Loosdrecht, MD, Lionel Ades, MD, Amer M Zeidan, MD, Matteo G Della Porta, MD (2024). Data-driven, harmonized classification system for myelodysplastic syndromes: a consensus study from the International Consortium for Myelodysplastic Syndromes (icMDS), The Lancet Haematology, [2024]. Lancet Haematol, 11(11), e862-e872.
    2. Schwabkey ZI, Wiesnoski DH, Chang CC, Tsai WB, Pham D, Ahmed SS, Hayase T, Ortega Turrubiates MR, El-Himri RK, Sanchez CA, Hayase E, Frenk Oquendo AC, Miyama T, Halsey TM, Heckel BE, Brown AN, Jin Y, Raybaud M, Prasad R, Flores I, McDaniel L, Chapa V, Lorenzi PL, Warmoes MO, Tan L, Swennes AG, Fowler S, Conner M, McHugh K, Graf T, Jensen VB, Peterson CB, Do KA, Zhang L, Shi Y, Wang Y, Galloway-Pena JR, Okhuysen PC, Daniel-MacDougall CR, Shono Y, Burgos da Silva M, Peled JU, van den Brink MRM, Ajami N, Wargo JA, Reddy P, Valdivia RH, Davey L, Rondon G, Srour SA, Mehta RS, Alousi AM, Shpall EJ, Champlin RE, Shelburne SA, Molldrem JJ, Jamal MA, Karmouch JL, Jenq RR (2022). Diet-derived metabolites and mucus link the gut microbiome to fever after cytotoxic cancer treatment. Sci Transl Med, 14(671), eabo3445. (Read full article)
    3. Schwabkey Z, Al Ali N, Sallman D, Kuykendall A, Talati C, Sweet K, Lancet J, Padron E, Komrokji R (2021). Impact of obesity on survival of patients with myelodysplastic syndromes. Hematology, 26(1), 393-397. (Read full article)
    4. Schwabkey ZI, Al Ali N, Chan O, Sallman DA, Padron E, Kuykendall AT, Talati C, Sweet K, Lancet JE, Komrokji RS (2020). Fluorescence in Situ Hybridization (FISH) Utility for Risk Score Assessment in Patients With MDS With Normal Metaphase Karyotype. Clin Lymphoma Myeloma Leuk, 21(1), e52-e56. (Read full article)
    5. Schwabkey ZI, Sheehan FC, Bellomo C, Raval M (2020). Congenital dysfibrinogenaemia presented with preterm premature rupture of the membranes and vaginal bleeding. BMJ Case Rep, 13(9). (Read full article)

    Review

    1. Schwabkey ZI, Jenq RR (2020). Microbiome Anomalies in Allogeneic Hematopoietic Cell Transplantation. [Review]. Annu Rev Med, 71, 137-148. (Read full article)
    2. Slingerland AE, Schwabkey Z, Wiesnoski DH, Jenq RR (2017). Clinical Evidence for the Microbiome in Inflammatory Diseases. [Review]. Front Immunol, 8, 400. (Read full article)

    Book Chapter

    1. Sallman D, Schwabkey Z, Deutsch Y (2024). Aplastic Anemia. In Non-malignant hematologic disorders (1st Edition).
    2. Schwabkey Z, Abushukair H, Kareem SS, Benson K (2024). Recombinant Human Plasma Proteins in Clinical Practice. In Non-malignant hematologic disorders (1st Edition).
    3. Schwabkey Z, Pinilla J (2024). Chronic Myelogenous Leukemia. In Handbook of Hematologic Malignancies (3rd Edition).
    4. Schwabkey Z, Kuykendall A (2024). Polycythema Vera. In Handbook of Hematologic Malignancies (3rd Edition - In Press).
    5. Schwabkey Z, Kuyekndall A (2024). Essential Thrombocythemia. In Handbook of Hematologic Malignancies (3rd Edition - In Press).